All Pharma News
OnKure hitches Reneo’s ride to Nasdaq, with $65M PIPE to boot

OnKure hitches Reneo’s ride to Nasdaq, with $65M PIPE to boot
Max Bayer FIERCE BIOTECH
13 May 2024
Share Share
Scorpion Therapeutics Appoints Adam Friedman as Chief Executive Officer

Scorpion Therapeutics Appoints Adam Friedman as Chief Executive Officer
BUSINESSWIRE
04 Jan 2024
Share Share
Axel Hoos and Michael Streit depart Scorpion

Axel Hoos and Michael Streit depart Scorpion
Gabrielle Masson FIERCE BIOTECH
04 Jan 2024
Share Share
Scorpion Appoints Precision Medicine Leader Jeff Albers as Strategic Advisor

Scorpion Appoints Precision Medicine Leader Jeff Albers as Strategic Advisor
BUSINESSWIRE
24 Oct 2023
Share Share
Scorpion Therapeutics Presents Preclinical Data for STX-241

Scorpion Therapeutics Presents Preclinical Data for STX-241
BUSINESSWIRE
13 Oct 2023
Share Share
Scorpion and Pierre Announce First Patient Dosed in Phase 1/2 Trial of STX-721

Scorpion and Pierre Announce First Patient Dosed in Phase 1/2 Trial of STX-721
PR NEWSWIRE
10 Oct 2023
Share Share
Scorpion Therapeutics Announces First Patient Dosed in Ph1/2 Trial of STX-478

Scorpion Therapeutics Announces First Patient Dosed in Ph1/2 Trial of STX-478
BUSINESSWIRE
02 May 2023
Share Share
Scorpion bags $553M deal for preclinical lung cancer assets

Scorpion bags $553M deal for preclinical lung cancer assets
Gabrielle Masson FIERCE BIOTECH
05 Apr 2023
Share Share
Scorpion and Pierre Announce Collaboration to Co-Develop STX-721 and STX-241

Scorpion and Pierre Announce Collaboration to Co-Develop STX-721 and STX-241
BUSINESSWIRE
04 Apr 2023
Share Share
Scorpion Therapeutics Nominates STX-241 as EGFR Inhibitor Development Candidate

Scorpion Therapeutics Nominates STX-241 as EGFR Inhibitor Development Candidate
BUSINESSWIRE
03 Apr 2023
Share Share